SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 28,080.80 |
| Enterprise Value ($M) | 33,692.40 |
| Book Value ($M) | 15,213.00 |
| Book Value / Share | 104.66 |
| Price / Book | 1.85 |
| NCAV ($M) | -4,598.40 |
| NCAV / Share | -31.63 |
| Price / NCAV | -6.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.32 |
| Current Ratio | 2.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6,756.20 |
| Assets | 26,567.60 |
| Liabilities | 11,354.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9,835.60 |
| Operating Income | 1,895.00 |
| Net Income | 1,161.10 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 1,547.20 |
| Cash from Investing | -4,101.00 |
| Cash from Financing | 149.30 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Primecap Management Co/ca/ | 11.22 | 3.59 | |
| 13G/A | Vanguard Group Inc | 10.02 | 21.25 | |
| 13G/A | BlackRock Inc. | 9.80 | -0.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 576,269 | 2,592,514 | 22.23 | |
| 279,196 | 1,243,882 | 22.45 | |
| 361,731 | 1,119,536 | 32.31 | |
| 355,637 | 637,460 | 55.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BCRX – BioCryst Pharmaceuticals, Inc. | BDTX – Black Diamond Therapeutics, Inc. |
| BEAM – Beam Therapeutics Inc. | BLUE – bluebird bio, Inc. |
| BMEA – Biomea Fusion, Inc. |
Financial data and stock pages provided by
Fintel.io